Macrophages: Potential Therapeutic Target of Myocardial Injury in COVID-19

Circ Res. 2021 Jun 25;129(1):47-49. doi: 10.1161/CIRCRESAHA.121.319446. Epub 2021 Jun 24.

Authors

Masataka Nishiga^{1

2}, Joseph C Wu^{1

2

3}

Affiliations

¹ Stanford Cardiovascular Institute (M.N., J.C.W.), Stanford University School of Medicine, CA.
² Department of Medicine, Division of Cardiovascular Medicine (M.N., J.C.W.), Stanford University School of Medicine, CA.
³ Department of Radiology (J.C.W.), Stanford University School of Medicine, CA.

No abstract available

Keywords: COVID-19; Editorials; macrophage; myocyte, cardiac; pluripotent stem cell.

Publication types

Editorial
Comment

MeSH terms

COVID-19*
Humans
Macrophages
Myocardium
SARS-CoV-2